Wastewater-Based Genomic Surveillance of SARS-CoV-2 Variant Circulation in Two Informal Urban Settlements in Nairobi, Kenya

This study demonstrates that wastewater-based genomic surveillance in two Nairobi informal settlements effectively tracked SARS-CoV-2 variant circulation, identifying Omicron as the predominant strain and providing a cost-effective, reliable complement to clinical surveillance in resource-limited settings.

The Gist

Imagine the city of Nairobi as a giant, bustling house where thousands of people live, work, and move around. In this house, there's a hidden "report card" being written every single day, not on paper, but in the sewage pipes flowing beneath the streets.

This research paper is about a team of scientists who decided to read that report card to see what kind of invisible "invaders" (viruses) were moving through two very crowded neighborhoods: Eastleigh A and Mathare.

Here is the story of their discovery, broken down simply:

1. The Problem: The "Blind Spot"

Usually, when a virus like SARS-CoV-2 (the virus that causes COVID-19) spreads, we only know about it when people get sick enough to go to a doctor and get tested. But in crowded, informal settlements, many people don't have easy access to clinics, or they don't feel sick enough to go. It's like trying to count the fish in a dark ocean by only looking at the ones that jump out of the water. You miss a lot of them.

2. The Solution: The "Sewage Super-Spy"

The scientists used a clever trick called Wastewater-Based Epidemiology (WBE). Think of the sewer system as a giant, natural "mixing bowl." Every day, people shed tiny bits of the virus in their poop, whether they are sick or not.

Instead of chasing individual people, the scientists went to the sewer pipes and used special "sponges" (called Moore swabs) to soak up the water for 24 hours. This sponge acted like a magnet, catching every tiny piece of virus floating by. It gave them a snapshot of the entire neighborhood's health, not just the people who went to the hospital.

3. The Investigation: Reading the "Genetic Fingerprint"

Once they brought the sponges back to the lab, they didn't just look for the virus; they looked for its ID card (its genome).

• The Process: They filtered the water, extracted the virus's genetic code, and used a high-tech machine (like a super-fast photocopier) to read the virus's DNA.
• The Result: Out of 272 samples they checked, almost 9 out of 10 had the virus. This told them the virus was very active in these neighborhoods.

4. The Cast of Characters: Who Was Circulating?

The scientists wanted to know which version of the virus was running around. They found that the Omicron family was the main character, showing up in 59% of the samples. It was the "boss" of the neighborhood.

However, they also spotted other characters:

• XBB: The second most common.
• XBB.2.3: A new player that started small but grew to become very popular by the end of the year.
• Old Ghosts: They even found an older version (BA.1) that the doctors had stopped seeing in clinics, but the sewage said, "Hey, this guy is still hanging out here!"

5. The "Early Warning System"

This is the most exciting part. The sewage acted like a canary in a coal mine.

• The Scenario: In the first quarter of the year, the sewage in Eastleigh A detected a new variant (XBB.2.3) before any doctors in Kenya had reported it in patients.
• The Metaphor: Imagine a smoke detector going off before you see the fire. The sewage told the health officials, "Heads up! A new virus is arriving," giving them time to prepare before the hospitals got overwhelmed.

6. The Neighborhood Differences

Even though the two neighborhoods are close to each other, they had different "vibes."

• Eastleigh A (a busy commercial hub) saw certain variants linger longer.
• Mathare (a massive residential area) saw different patterns, likely because people moved in and out differently, or because the sewer pipe there collected water from a wider mix of people, including parts of the city center.

7. The Big Takeaway

The study proved that sewage is a reliable mirror of what's happening in the community.

• It's Cheaper: You don't need to test thousands of individuals; you just test the pipes.
• It's Fairer: It catches the virus from everyone, rich or poor, sick or healthy, who uses the toilet.
• It's Faster: It spots new threats earlier than clinical testing.

The Conclusion

The scientists are saying: "Don't ignore the pipes!" By listening to what the wastewater is saying, Kenya (and other countries with limited resources) can get a clear, early warning about which viruses are spreading. It's a low-tech, high-smart way to keep the whole city safe, acting as a community-wide health check-up that never sleeps.

In short: They turned the city's sewage into a crystal ball, allowing them to see the future of virus spread before it became a crisis.

Technical Summary

1. Problem Statement

• Surveillance Gaps in LMICs: Genomic surveillance data for SARS-CoV-2 remains scarce in Low- and Middle-Income Countries (LMICs), creating significant blind spots regarding variant circulation and evolution.
• Limitations of Clinical Testing: Conventional clinical surveillance is hindered by constrained healthcare infrastructure, limited access to testing in densely populated informal settlements, and an inability to capture asymptomatic infections.
• The Need for Alternatives: There is a critical need for non-invasive, cost-effective, and population-representative surveillance methods to complement clinical data, particularly in urban informal settlements like those in Nairobi, Kenya.

2. Methodology

Study Design & Setting:

• Type: Prospective observational study conducted between December 2022 and October 2023.
• Locations: Two WHO-validated environmental surveillance sites in Nairobi's informal settlements:
  1. Eastleigh A (Kamukunji sub-county): A high-density commercial/residential hub (Population: ~65,703).
  2. Mathare (Starehe sub-county): One of the city's largest informal settlements with diverse catchment areas including parts of the Central Business District (Population: ~29,717).
• Sampling: 272 wastewater samples were collected using Moore swabs (autoclaved cotton gauze) deployed for 24-hour passive collection periods. Sampling frequency increased from twice to three times weekly.

Laboratory Workflow:

• Concentration: Samples were concentrated using Nanotrap® Magnetic Virus Particles.
• Extraction: Nucleic acid extraction performed via the Qiagen QIAamp Viral RNA Mini Kit.
• Detection: SARS-CoV-2 presence confirmed via RT-PCR (TaqPath™ kit) on a QuantStudio 5 system. Positivity defined as Cycle Threshold (Ct) < 36.
• Sequencing:
  • Library preparation using the Illumina COVIDSeq kit.
  • Sequencing performed on the Illumina MiSeq platform (paired-end).
• Bioinformatics:
  • Analysis conducted using Terra.bio and RStudio.
  • Phylogenetic Analysis: Compared 28 wastewater sequences (≥50% genome coverage) against 175 clinical sequences from GISAID (Kenya, May–Oct 2023) to assess clustering and variant lineage.

3. Key Contributions

• Pilot Implementation: Successfully piloted wastewater-based genomic surveillance (WBE) in two distinct informal urban settlements in Kenya, demonstrating feasibility in resource-limited settings.
• Early Warning Capability: Provided evidence that WBE can detect variant emergence earlier than clinical surveillance.
• Hidden Lineage Detection: Identified circulating lineages (specifically BA.1/21K) in wastewater that were absent from available clinical sequencing data, highlighting WBE's ability to capture underrepresented variants.
• Validation: Validated the concordance between wastewater genomic data and national clinical sequencing trends.

4. Key Results

Detection Rates:

• 238 out of 272 samples (87.5%) tested positive for SARS-CoV-2 (Ct < 36).
• Temporal variation in Ct values correlated with fluctuating community infection levels.

Variant Distribution (Overall):

• Omicron was the predominant variant, accounting for 59% of all sequences.
• Other detected variants included XBB (16%), XBB.2.3 (10%), and XBB.1.9.X (5%).
• These findings were highly concordant with clinical sequencing data from Kenya during the same period.

Temporal Dynamics (Quarterly Analysis):

• Omicron: Persisted throughout all four quarters (Q1–Q4), peaking in Q3.
• XBB: Peaked in Q2 and declined significantly by Q3/Q4.
• XBB.1.9.X: Dominant in Q1 but disappeared by Q3. Notably, it was detected in wastewater earlier than in clinical samples.
• XBB.2.3: Emerged in Q1 (Kamukunji) and Q2 (Mathare), showing a progressive increase to become a dominant strain in Mathare by Q4 (50% relative abundance).
• BA.1 (21K): Detected in wastewater samples from September–October 2023, despite being absent from clinical data, suggesting prolonged community circulation missed by clinical testing.

Phylogenetic Analysis:

• Wastewater sequences clustered within the same major clades (23B, 23D, 23E, 23F) as clinical sequences from Kenya.
• Sequences aligned with GISAID data from Nairobi, Nakuru, Kiambu, and Machakos, confirming representativeness.

5. Significance and Recommendations

Significance:

• Public Health Utility: WBE serves as a robust, cost-effective early warning system for variant emergence, allowing authorities to prepare responses before clinical case counts rise.
• Equity: It effectively monitors high-risk, underserved populations in informal settlements where clinical testing is logistically difficult.
• Data Completeness: It captures a more comprehensive picture of viral diversity, including lineages that may be under-sampled in clinical settings.

Limitations:

• RNA Degradation: Extended storage of RNA extracts (up to one year) led to fragmentation and reduced genome coverage.
• Lack of Quantification: The study relied on Ct values rather than absolute viral load quantification.
• Data Correlation: Lack of paired clinical data from the specific catchment areas limited individual-level correlation.
• Generalizability: Findings are specific to two sites in Nairobi and may not represent the entire Kenyan or African context without broader scaling.

Recommendations:

• Scale-Up: Formally expand WBE to multiple sites for nationally representative data.
• Methodological Optimization: Perform sequencing within six months of RNA extraction to preserve genomic integrity.
• Quantitative Integration: Incorporate quantitative PCR to estimate viral loads.
• Broadened Scope: Expand surveillance to other pathogens (Influenza, Cholera, Measles) and antimicrobial resistance (AMR) gene signatures.